Uk Kotze
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Uk Kotze has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Marc Bernon
Surgical Gastroenterology Unit, Division of General Surgery, Department of Surgery, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
8 shared publications - Eduard Jonas
Surgical Gastroenterology Unit, Division of General Surgery, Department of Surgery, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
7 shared publications Jej Krige
Surgical Gastroenterology Unit, Division of General Surgery, Department of Surgery, Faculty of Health Sciences, Groote Schuur Hospital, University of Cape Town, South Africa
4 shared publications- S. Burmeister
Hepatobiliary Unit, Department of Surgery, Groote Schuur Hospital, University of Cape Town
4 shared publications - Muhammad Emmamally
Surgical Gastroenterology Unit, Division of General Surgery, Department of Surgery, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
3 shared publications R Khan
Surgical Gastroenterology Unit, Division of General Surgery, Department of Surgery, Faculty of Health Sciences, Groote Schuur Hospital, University of Cape Town, South Africa
3 shared publications
Latest Publications
- 1 March 2026
- Published by Medpharm Publications in South African Journal of Surgery
- Vol. 64 (1) , 44-47
Preventing the preventable: Adolescent hepatocellular carcinoma and implications for hepatitis B virus prevention policy in South Africa
Hepatocellular carcinoma (HCC) is a fatal disease of the young in sub-Saharan Africa (SSA) and chronic hepatitis B virus (HBV) infection remains the predominant aetiology. There is paucity of data regarding HCC in the adolescent population globally. Adolescents, defined as individuals aged 10 to 19 years according to the World Health Organization (WHO), with HCC treated at Groote Schuur Hospital (GSH) in South Africa from 1 January 2012 and 31 December 2024 were studied. Five (0.5%) of the 726 HCC patients managed at GSH during the study period were adolescents. The median age was 18 (13-19) years and three were female. All five had chronic HBV infection and most presented with pain (60%) and/ or an abdominal mass (40%). All had advanced disease, with four (80%) having Barcelona Clinic Liver Cancer (BCLC) stage C and one (20%) with BCLC stage D. Two (40%) had extrahepatic metastases and three (60%) had portal vein tumour thrombosis. Treatment included liver resection (1), sorafenib (1), lenvatinib (1), and best supportive care (2). At the time of the study, only one patient was alive. The median survival was 137 (25-425) days. Despite national HBV vaccination programmes in South Africa, in our experience adolescent HCC was HBV-related in all five patients. Extrahepatic metastases and macrovascular invasion were frequently reported and restricted patient access to curative-intended therapies (ablation, liver resection, transplantation). These findings highlight the urgent need for improved early detection and prevention strategies against perinatal HBV transmission in South Africa, including the rollout of the WHO-recommended universal hepatitis B birth-dose vaccination rather than the current targeted prevention approach.
- 1 March 2026
- Published by Medpharm Publications in South African Journal of Surgery
- Vol. 64 (1) , 44-47
Preventing the preventable: Adolescent hepatocellular carcinoma and implications for hepatitis B virus prevention policy in South Africa
Hepatocellular carcinoma (HCC) is a fatal disease of the young in sub-Saharan Africa (SSA) and chronic hepatitis B virus (HBV) infection remains the predominant aetiology. There is paucity of data regarding HCC in the adolescent population globally. Adolescents, defined as individuals aged 10 to 19 years according to the World Health Organization (WHO), with HCC treated at Groote Schuur Hospital (GSH) in South Africa from 1 January 2012 and 31 December 2024 were studied. Five (0.5%) of the 726 HCC patients managed at GSH during the study period were adolescents. The median age was 18 (13-19) years and three were female. All five had chronic HBV infection and most presented with pain (60%) and/ or an abdominal mass (40%). All had advanced disease, with four (80%) having Barcelona Clinic Liver Cancer (BCLC) stage C and one (20%) with BCLC stage D. Two (40%) had extrahepatic metastases and three (60%) had portal vein tumour thrombosis. Treatment included liver resection (1), sorafenib (1), lenvatinib (1), and best supportive care (2). At the time of the study, only one patient was alive. The median survival was 137 (25-425) days. Despite national HBV vaccination programmes in South Africa, in our experience adolescent HCC was HBV-related in all five patients. Extrahepatic metastases and macrovascular invasion were frequently reported and restricted patient access to curative-intended therapies (ablation, liver resection, transplantation). These findings highlight the urgent need for improved early detection and prevention strategies against perinatal HBV transmission in South Africa, including the rollout of the WHO-recommended universal hepatitis B birth-dose vaccination rather than the current targeted prevention approach.
- 1 December 2025
- Published by Medpharm Publications in South African Journal of Surgery
- Vol. 63 (4) , 222-228
Preoperative risk factors for 90-day postoperative mortality in patients with pancreatic ductal adenocarcinoma: a cohort-based study
Pancreatic ductal adenocarcinoma (PDAC) has a 5-year survival rate of less than 10%. Treatment with curative intent surgery still poses high rates of overall postoperative morbidity (68.7%) and mortality (5.4%). It is therefore essential to identify preoperative factors influencing early postoperative outcomes to provide better insight for improved patient selection and care. Sixty patients diagnosed with PDAC who had undergone surgical resection at Groote Schuur Hospital, Cape Town, between 2016 and 2023 were included. The patient cohort was divided into two groups, postoperative survival ≤ 90 days vs > 90 days. The groups were compared regarding demographic and preoperative assessment tools using ASA, ECOG and Codman scores, baseline clinical and imaging data, preoperative treatment and surgical related parameters. Significant differences were found in patients, with patients presenting with pancreatic duct dilation (p < 0.05), tumour location in the pancreatic head (p < 0.05), elevated gamma-glutamyl transferase (GGT) (p < 0.01) and carbohydrate antigen 19-9 (CA19-9) (p < 0.05). Using regression analysis, GGT serum levels > 500 U/L were correlated with mortality ≤ 90 days, while pancreatic duct dilatation and CA19-9 levels > 200 U/L were associated with survival > 90 days. The results of this study present important insights regarding risk factors influencing postoperative mortality and offer a potential roadmap for optimising preoperative care and judicious patient selection before pancreatic surgery.
- 1 December 2025
- Published by Medpharm Publications in South African Journal of Surgery
- Vol. 63 (4) , 222-228
Preoperative risk factors for 90-day postoperative mortality in patients with pancreatic ductal adenocarcinoma: a cohort-based study
Pancreatic ductal adenocarcinoma (PDAC) has a 5-year survival rate of less than 10%. Treatment with curative intent surgery still poses high rates of overall postoperative morbidity (68.7%) and mortality (5.4%). It is therefore essential to identify preoperative factors influencing early postoperative outcomes to provide better insight for improved patient selection and care. Sixty patients diagnosed with PDAC who had undergone surgical resection at Groote Schuur Hospital, Cape Town, between 2016 and 2023 were included. The patient cohort was divided into two groups, postoperative survival ≤ 90 days vs > 90 days. The groups were compared regarding demographic and preoperative assessment tools using ASA, ECOG and Codman scores, baseline clinical and imaging data, preoperative treatment and surgical related parameters. Significant differences were found in patients, with patients presenting with pancreatic duct dilation (p < 0.05), tumour location in the pancreatic head (p < 0.05), elevated gamma-glutamyl transferase (GGT) (p < 0.01) and carbohydrate antigen 19-9 (CA19-9) (p < 0.05). Using regression analysis, GGT serum levels > 500 U/L were correlated with mortality ≤ 90 days, while pancreatic duct dilatation and CA19-9 levels > 200 U/L were associated with survival > 90 days. The results of this study present important insights regarding risk factors influencing postoperative mortality and offer a potential roadmap for optimising preoperative care and judicious patient selection before pancreatic surgery.
- 1 June 2024
- Published by Medpharm Publications in South African Journal of Surgery
- Vol. 62 (2) , 108-113
Outcomes of jaundice in advanced hepatocellular carcinoma – a sub-Saharan perspective
BackgroundJaundice is a marker of advanced disease and poor outcomes in hepatocellular carcinoma (HCC). The aim of this study was to describe and analyse the management and outcomes of jaundiced HCC patients at a large academic referral centre in sub-...
- 1 June 2024
- Published by Medpharm Publications in South African Journal of Surgery
- Vol. 62 (2) , 108-113
Outcomes of jaundice in advanced hepatocellular carcinoma – a sub-Saharan perspective
BackgroundJaundice is a marker of advanced disease and poor outcomes in hepatocellular carcinoma (HCC). The aim of this study was to describe and analyse the management and outcomes of jaundiced HCC patients at a large academic referral centre in sub-...
- 1 June 2024
- Published by Medpharm Publications in South African Journal of Surgery
- Vol. 62 (2) , 142-148
Pancreaticoduodenectomy for distal cholangiocarcinoma at a South African centre
Background: Surgical resection of distal cholangiocarcinoma (dCCA) offers the only chance for cure and long-term survival. The current literature provides limited data regarding the surgical management and long-term outcomes of dCCA. This study aims to describe the presentation, management, and outcomes of dCCA at a large academic referral centre in South Africa. Methods: A retrospective study was performed of all patients who underwent curative-intended surgery for dCCA at Groote Schuur Hospital from 2000 to 2020. Results: Over 21 years, 25 patients underwent pancreaticoduodenectomy (PD) for dCCA. Most patients were male (68%), and the mean age was 56.8 years. Of the patients, 22 (84%) underwent preoperative biliary drainage (PBD). There were 29 recorded complications in 25 patients; postoperative pancreatic fistula (POPF) and surgical site infection (SSI) each occurred in 24% of the cohort. The mean hospital stay was 17.2 days without perioperative mortality. With none lost to follow-up, the 1, 3, 5, 10, and 20-year survival rates were 84%, 24%, 16%, 12%, and 4%, respectively. Only T3 status was associated with significantly lower overall survival (OS). Age, albumin levels, PBD, margin status (R0 vs. R1), and nodal status (N0 vs. N1/N2) did not influence OS. Conclusions: This is the first study detailing the management and outcomes of dCCA from sub-Saharan Africa (SSA). Despite the complete resection of dCCA, the prognosis is poor, and the long-term survival rate in our study is equivalent to that reported in the literature. T3 disease is an important prognostic factor and is associated with poor OS. Surprisingly, nodal disease and margin status did not affect OS in the cohort of patients.
- 1 June 2024
- Published by Medpharm Publications in South African Journal of Surgery
- Vol. 62 (2) , 142-148
Pancreaticoduodenectomy for distal cholangiocarcinoma at a South African centre
Background: Surgical resection of distal cholangiocarcinoma (dCCA) offers the only chance for cure and long-term survival. The current literature provides limited data regarding the surgical management and long-term outcomes of dCCA. This study aims to describe the presentation, management, and outcomes of dCCA at a large academic referral centre in South Africa. Methods: A retrospective study was performed of all patients who underwent curative-intended surgery for dCCA at Groote Schuur Hospital from 2000 to 2020. Results: Over 21 years, 25 patients underwent pancreaticoduodenectomy (PD) for dCCA. Most patients were male (68%), and the mean age was 56.8 years. Of the patients, 22 (84%) underwent preoperative biliary drainage (PBD). There were 29 recorded complications in 25 patients; postoperative pancreatic fistula (POPF) and surgical site infection (SSI) each occurred in 24% of the cohort. The mean hospital stay was 17.2 days without perioperative mortality. With none lost to follow-up, the 1, 3, 5, 10, and 20-year survival rates were 84%, 24%, 16%, 12%, and 4%, respectively. Only T3 status was associated with significantly lower overall survival (OS). Age, albumin levels, PBD, margin status (R0 vs. R1), and nodal status (N0 vs. N1/N2) did not influence OS. Conclusions: This is the first study detailing the management and outcomes of dCCA from sub-Saharan Africa (SSA). Despite the complete resection of dCCA, the prognosis is poor, and the long-term survival rate in our study is equivalent to that reported in the literature. T3 disease is an important prognostic factor and is associated with poor OS. Surprisingly, nodal disease and margin status did not affect OS in the cohort of patients.
- 1 June 2024
- Published by Medpharm Publications in South African Journal of Surgery
- Vol. 62 (2) , 161-168
Intermediate and long-term survival prediction using prognostic scores in patients undergoing salvage TIPS for uncontrolled variceal bleeding
Background: This study investigated the value of prognostic scores to predict 90-day, 1-, 3- and 5-year survival after salvage TIPS (sTIPS) in patients with exsanguinating variceal bleeding who failed endoscopic intervention. Methods: The Model for End-Stage Liver Disease (MELD), Model for End-Stage Liver Disease Sodium (MELDNa), Acute Physiology and Chronic Health Evaluation II (APACHE II) and Child-Pugh (C-P) grades and scores were calculated using Kaplan-Meier curves and Cox proportional hazards models in sTIPS patients treated between August 1991 and November 2020. Results: Thirty-four patients (29 men, 5 women), mean age 52 years, SD +/- 11.6 underwent sTIPS which controlled bleeding in 32 (94%) patients. Ten (29.4%) patients died in hospital at a median of 4.8 (range 1-10) days. On bivariate analysis, C-P score >= 10 (p p = 0.017), high C-P grade (p p = 0.048), MELD >= 15 (p p = 0.010), MELD-Na score >= 22 (p p < 0.001) and APACHE II score >= 15 (p p < 0.001) predicted 90-day mortality. Individual clinical characteristics associated with 90-day mortality were grade 3 ascites (p p = 0.029), > 10 units of blood transfused (p p = 0.004), balloon tube placement (p p < 0.001), endotracheal intubation (< 0.001) and inotrope support (p p < 0.001). The overall 90-day, 1-, 3- and 5-year survival rates were 67.6%, 55.9%, 26.5% and 20.6% respectively. Nine patients (26.5%) were alive at a median of two years (range 1-18 years) post-TIPS. Patients with C-P grade A, C-P score < 10, MELD score < 15, MELD-Na score < 22 and APACHE II score < 15 had significantly better 90-day, 1-, 3- and 5-year survival rates. Conclusion: Although sTIPS controlled variceal bleeding in 94% of patients after failed endoscopic therapy, in-hospital mortality was 29% and less than one quarter were alive after five years. The selected cut-off values for the nominated scoring systems accurately predicted 90-day mortality and long-term survival.
- 1 June 2024
- Published by Medpharm Publications in South African Journal of Surgery
- Vol. 62 (2) , 161-168
Intermediate and long-term survival prediction using prognostic scores in patients undergoing salvage TIPS for uncontrolled variceal bleeding
Background: This study investigated the value of prognostic scores to predict 90-day, 1-, 3- and 5-year survival after salvage TIPS (sTIPS) in patients with exsanguinating variceal bleeding who failed endoscopic intervention. Methods: The Model for End-Stage Liver Disease (MELD), Model for End-Stage Liver Disease Sodium (MELDNa), Acute Physiology and Chronic Health Evaluation II (APACHE II) and Child-Pugh (C-P) grades and scores were calculated using Kaplan-Meier curves and Cox proportional hazards models in sTIPS patients treated between August 1991 and November 2020. Results: Thirty-four patients (29 men, 5 women), mean age 52 years, SD +/- 11.6 underwent sTIPS which controlled bleeding in 32 (94%) patients. Ten (29.4%) patients died in hospital at a median of 4.8 (range 1-10) days. On bivariate analysis, C-P score >= 10 (p p = 0.017), high C-P grade (p p = 0.048), MELD >= 15 (p p = 0.010), MELD-Na score >= 22 (p p < 0.001) and APACHE II score >= 15 (p p < 0.001) predicted 90-day mortality. Individual clinical characteristics associated with 90-day mortality were grade 3 ascites (p p = 0.029), > 10 units of blood transfused (p p = 0.004), balloon tube placement (p p < 0.001), endotracheal intubation (< 0.001) and inotrope support (p p < 0.001). The overall 90-day, 1-, 3- and 5-year survival rates were 67.6%, 55.9%, 26.5% and 20.6% respectively. Nine patients (26.5%) were alive at a median of two years (range 1-18 years) post-TIPS. Patients with C-P grade A, C-P score < 10, MELD score < 15, MELD-Na score < 22 and APACHE II score < 15 had significantly better 90-day, 1-, 3- and 5-year survival rates. Conclusion: Although sTIPS controlled variceal bleeding in 94% of patients after failed endoscopic therapy, in-hospital mortality was 29% and less than one quarter were alive after five years. The selected cut-off values for the nominated scoring systems accurately predicted 90-day mortality and long-term survival.
- 1 June 2024
- Published by Medpharm Publications in South African Journal of Surgery
- Vol. 62 (2) , 169-174
The role of endoscopic retrograde cholangiopancreatography in the treatment of hepatic cystic Echinococcus in a high HIV prevalence population: a retrospective cohort study
Background: Endoscopic retrograde cholangiopancreatography (ERCP) is a useful, minimally invasive intervention in managing complicated hepatic cystic echinococcosis (HCE). This study aims to assess the use of ERCP in a South African HCE cohort with and without human immunodeficiency virus (HIV) co-infection. Methods: An analysis was performed of patients with HCE who were assessed for surgery and underwent ERCP at a tertiary hospital in South Africa between 2011 and 2023. Demographics, clinical data, imaging characteristics, operative management, and postoperative complications were compared between HIV-negative (HIV-) and HIV-positive (HIV+) cohorts. Results: Of the 91 patients assessed, 45 (mean age 34.6 years, 73.3% females, 23 HIV+) required ERCP. HIV status did not significantly affect cyst characteristics or surgical outcomes. HIV+ patients had a higher incidence of intraoperative bile leaks (p p = 0.025). There were 18 patients who underwent preoperative ERCPs, mainly for biliary-cyst complications primarily causing obstructive jaundice. A total of 40 patients required postoperative ERCPs, mainly for bile leaks. There were no ERCP-related mortalities and only one case of pancreatitis. ERCP success rates were comparable in both cohorts, with an overall success rate of 86.7%. Conclusion: HIV co-infection did not significantly impact the clinical course or outcomes of cystic echinococcosis (CE) patients undergoing ERCP. Perioperative ERCP proved effective in managing biliary complications of HCE as well as postoperative complications, regardless of HIV status. This study underscores the importance of endoscopic interventions in the comprehensive management of CE.
- 1 June 2024
- Published by Medpharm Publications in South African Journal of Surgery
- Vol. 62 (2) , 169-174
The role of endoscopic retrograde cholangiopancreatography in the treatment of hepatic cystic Echinococcus in a high HIV prevalence population: a retrospective cohort study
Background: Endoscopic retrograde cholangiopancreatography (ERCP) is a useful, minimally invasive intervention in managing complicated hepatic cystic echinococcosis (HCE). This study aims to assess the use of ERCP in a South African HCE cohort with and without human immunodeficiency virus (HIV) co-infection. Methods: An analysis was performed of patients with HCE who were assessed for surgery and underwent ERCP at a tertiary hospital in South Africa between 2011 and 2023. Demographics, clinical data, imaging characteristics, operative management, and postoperative complications were compared between HIV-negative (HIV-) and HIV-positive (HIV+) cohorts. Results: Of the 91 patients assessed, 45 (mean age 34.6 years, 73.3% females, 23 HIV+) required ERCP. HIV status did not significantly affect cyst characteristics or surgical outcomes. HIV+ patients had a higher incidence of intraoperative bile leaks (p p = 0.025). There were 18 patients who underwent preoperative ERCPs, mainly for biliary-cyst complications primarily causing obstructive jaundice. A total of 40 patients required postoperative ERCPs, mainly for bile leaks. There were no ERCP-related mortalities and only one case of pancreatitis. ERCP success rates were comparable in both cohorts, with an overall success rate of 86.7%. Conclusion: HIV co-infection did not significantly impact the clinical course or outcomes of cystic echinococcosis (CE) patients undergoing ERCP. Perioperative ERCP proved effective in managing biliary complications of HCE as well as postoperative complications, regardless of HIV status. This study underscores the importance of endoscopic interventions in the comprehensive management of CE.
- 1 June 2024
- Published by Medpharm Publications in South African Journal of Surgery
- Vol. 62 (2) , 184-189
Audit of an in-patient palliative care quality improvement process for patients with pancreatic ductal adenocarcinoma in a South African teaching hospital
Background: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with poor survival rates. Timeously introduced palliative care (PC) improves the quality of life (QoL) for patients with terminal diseases. In 2020, an in-patient PC-quality improvement (QI) programme was implemented for PDAC patients. This study compared PC outcomes before and after the introduction of the PC-QI programme. Methods: A focus group identified five critical intervention areas that could improve care. These were in-patient PC referral, pain and symptom control, shared decision-making, interdisciplinary collaborative care, and continuity of care. A hospital record audit of PDAC patients was conducted in pre- and post-implementation cohorts, and the results were compared. Results: A total of 68 (2017 pre-PC-QI) and 39 (2022 post-PC-QI) patient records were audited. Demography, symptom duration, referral delay, and clinical findings were similar in both cohorts. In-patient PC referrals improved significantly from 54.4% in 2017 to 82.1% in 2022 (p p = 0.0059). Significant improvements were also recorded in shared decision- making, collaboration, and continuity of care, while the reassessment of pain and symptoms after treatment improved. Fewer invasive procedures were done in the 2022 cohort (p p = 0.0056). The delay from admission to an invasive diagnostic procedure decreased from a mean of 8.7 to 1.5 days (p p = 0.0001). The duration of hospital admission, overall survival (OS), and readmissions during the final 30 days of life were similar. Conclusion: The QI programme resulted in improved use of the in-hospital PC service and made better use of scarce resources. Increasing patient and family participation and feedback will further inform the development of the quality of PC services.
- 1 June 2024
- Published by Medpharm Publications in South African Journal of Surgery
- Vol. 62 (2) , 184-189
Audit of an in-patient palliative care quality improvement process for patients with pancreatic ductal adenocarcinoma in a South African teaching hospital
Background: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with poor survival rates. Timeously introduced palliative care (PC) improves the quality of life (QoL) for patients with terminal diseases. In 2020, an in-patient PC-quality improvement (QI) programme was implemented for PDAC patients. This study compared PC outcomes before and after the introduction of the PC-QI programme. Methods: A focus group identified five critical intervention areas that could improve care. These were in-patient PC referral, pain and symptom control, shared decision-making, interdisciplinary collaborative care, and continuity of care. A hospital record audit of PDAC patients was conducted in pre- and post-implementation cohorts, and the results were compared. Results: A total of 68 (2017 pre-PC-QI) and 39 (2022 post-PC-QI) patient records were audited. Demography, symptom duration, referral delay, and clinical findings were similar in both cohorts. In-patient PC referrals improved significantly from 54.4% in 2017 to 82.1% in 2022 (p p = 0.0059). Significant improvements were also recorded in shared decision- making, collaboration, and continuity of care, while the reassessment of pain and symptoms after treatment improved. Fewer invasive procedures were done in the 2022 cohort (p p = 0.0056). The delay from admission to an invasive diagnostic procedure decreased from a mean of 8.7 to 1.5 days (p p = 0.0001). The duration of hospital admission, overall survival (OS), and readmissions during the final 30 days of life were similar. Conclusion: The QI programme resulted in improved use of the in-hospital PC service and made better use of scarce resources. Increasing patient and family participation and feedback will further inform the development of the quality of PC services.